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Changes in human gait resulting from ageing or neurodegenerative diseases are multifactorial. Here we 
assess the effects of age and Parkinson’s disease (PD) on corticospinal activity recorded during treadmill 
and overground walking. Electroencephalography (EEG) from 10 electrodes and electromyography 
(EMG) from bilateral tibialis anterior muscles were acquired from 22 healthy young, 24 healthy older 
and 20 adults with PD. Event-related power, corticomuscular coherence (CMC) and inter-trial coherence 
were assessed for EEG from bilateral sensorimotor cortices and EMG during the double-support phase 
of the gait cycle. CMC and EMG power at low beta frequencies (13–21 Hz) was significantly decreased in 
older and PD participants compared to young people, but there was no difference between older and 
PD groups. Older and PD participants spent shorter time in the swing phase than young individuals. 
These findings indicate age-related changes in the temporal coordination of gait. The decrease in low-
beta CMC suggests reduced cortical input to spinal motor neurons in older people during the double-
support phase. We also observed multiple changes in electrophysiological measures at low-gamma 
frequencies during treadmill compared to overground walking, indicating task-dependent differences in 
corticospinal locomotor control. These findings may be affected by artefacts and should be interpreted 
with caution.
Human gait is known to change with age and to be affected by neurodegenerative diseases such as Parkinson’s 
disease (PD). Changes in gait often affect mobility and activities of daily living, and increase the risk for falls, 
disability, morbidity, and mortality in these populations1–3. Mechanical and dynamical changes in gait have been 
well documented. Older adults are known to walk slower, take shorter strides, spend more time in stance and 
double support, use their hip extensors more, and their ankle plantar flexors and knee extensors less than young 
individuals4–10. Movement kinematics, including joint moments and powers at the ankle, and ground reaction 
forces, also change with ageing11. PD gait is characterised by slowness, increased variability and impaired postural 
control1,12–16. Many stride parameters are altered in people with PD compared to age-matched controls, including 
decreased walking velocity, stride length, cadence, arm swing, head-trunk control and single support time17,18. 
Spatial and temporal gait parameters are also more variable15 and more asymmetric1. In addition, PD patients 
may experience episodic gait disturbances such as freezing or festination of gait1,12,19. In recent years, tread-
mill training has been increasingly used to improve gait in PD and its therapeutic effects are greatly discussed. 
Beneficial effects of treadmill training have been reported for gait speed, step length, stride variability, balance 
and freezing20–25. Notably, treadmill walking has been shown to alter gait kinematics and leg muscle activation 
compared to overground walking in both healthy adults26–29 and in people with PD30–34.
The neural mechanisms associated with age- and disease-related gait changes have been investigated using 
neuroimaging techniques, such as functional magnetic resonance imaging (fMRI), near-infrared spectroscopy 
(NIRS) and electroencephalography (EEG). Studies using these imaging techniques have shown that gait-related 
brain activity differs in older adults and people with PD35–40. For example, older adults exhibit greater activity in 
various cortical regions including motor, somatosensory, visual and frontal cortices than young individuals dur-
ing gait imagery as revealed by fMRI41–43. In people with PD, fMRI studies have shown that neural activity during 
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gait imagery tasks is altered in various brain regions compared to age-matched controls44–46, and that freezing of 
gait is associated with impaired functional connectivity between neural networks47,48. Moreover, regional cer-
ebral blood flow in the supplementary motor area (SMA) was found to be decreased during treadmill walking 
in people with PD compared to healthy controls as detected by SPECT49. While these studies indicate changes 
in gait-related brain activity that occur with ageing and PD, they are limited to imagined gait (or recordings 
after the performance of walking tasks) and may not apply to real walking as participants cannot move during a 
fMRI scan. NIRS, on the other hand, is a mobile imaging technique that allows capturing changes in oxygenated 
haemoglobin levels during walking. Using NIRS, Harada et al.50 found that the SMA, sensorimotor cortices and 
the prefrontal cortex are involved in gait control in healthy older people. Prefrontal cortical activity has been 
observed to decrease during walking with additional cognitive tasks in older but not in young people51 and has 
been observed to predict falls52. In people with PD, oxygenated haemoglobin levels over frontal and pre-frontal 
regions have been reported to be sensitive to freezing of gait (FOG) episodes, walking with obstacle crossings and 
dual-task walking53–56.
EEG can be used to record electrical activity of the brain during walking with high temporal resolution. EEG 
signals can be analysed in the time (event-related potentials) and frequency (oscillatory activity) domain to 
investigate cortical control of gait. EEG acquired during treadmill walking has revealed delayed and diminished 
event-related potentials in response to a cognitive go/no-go task in older compared to young adults57. In peo-
ple with PD, movement-related cortical potentials during a gait initiation task were also reduced compared to 
healthy young people58. Time-frequency analysis revealed that cortical oscillations were modulated by age and 
PD. EEG gamma power over frontal cortices was enhanced in older people during dual-task walking59. Theta and 
low-gamma power was increased during turning with freezing of gait in people with PD compared to normal flu-
ent turning in a number of cortical regions60,61. Interestingly, previous research has also demonstrated that people 
with PD show abnormalities in beta oscillatory activity in the basal ganglia (subthalamic nucleus, STN) and cer-
ebral cortex at rest as well as during movement62–67. For instance, at rest in an untreated state (after a medication 
wash-out period and STN deep brain stimulating (DBS) electrodes switched off), beta power in the STN and beta 
activity amongst basal ganglia-cortical networks was increased compared to an optimally medicated state and 
STN DBS switched on68–72. Notably, walking and cycling was found to decrease STN beta power in people with 
PD73–75. Moreover, stepping movements have been shown to modulate STN beta power relative to the movement 
phase (suppressed during contralateral foot lift)74. Some disturbances in gait-related brain activity may be due to 
the dopamine deficit in the basal ganglia–thalamo–cortical circuit in PD, but other pathways, including cortical 
cholinergic deficits, may also contribute to PD gait disorders1,37,76.
Although both the changes in brain activity and movement kinematics during gait in older people and PD 
have been extensively documented, it is not clearly understood how these changes are related. How do the 
changes in brain activity result in the specific gait changes observed with ageing and in PD? Investigating func-
tional interactions between the central and peripheral nervous system may help to address this research question. 
For example, corticomuscular (EEG-EMG) coherence has revealed correlated activity in the beta band that likely 
reflects efferent activity from corticospinal projections77,78. While corticomuscular coherence has been mainly 
investigated during precision grip tasks, it has also been assessed during walking79. We recently showed that in 
young healthy adults corticomuscular coherence is observed during the double support phase of the gait cycle 
and largely absent during the swing phase, and that treadmill walking reduces corticomuscular coherence at high 
beta frequencies compared to walking overground80. Using directed connectivity analysis, Artoni et al.81 showed 
that the functional interactions during normal walking primarily reflect unidirectional drive from contralateral 
motor cortex to muscles. Changes in corticomuscular coherence with ageing and PD has not yet been investi-
gated during walking, but a few studies have investigated it in other tasks. During cyclical ankle movements – as 
a simulation of rhythmic natural walking – corticomuscular coherence was reduced in older compared to young 
participants82, but it was not different between people with PD and age-matched controls even though movement 
performance varied between these groups83. Notably, beta-band coherence was enhanced in older compared to 
young participants during abduction of the index finger84, although others reported it reduced during elbow flex-
ion85,86. Interestingly, levels of corticomuscular beta-band coherence during forearm contractions were found to 
be similar in people with PD and age-matched controls87,88. Yet, STN DBS has been observed to enhance cortico-
muscular beta-band coherence in people with PD during a precision grip task89, and levodopa medication during 
forearm contractions has been found to reduce it87.
In this study we aimed to investigate whether corticomuscular coherence during walking is affected in older 
people and people with PD. We therefore collected ambulatory EEG and EMG during overground and treadmill 
walking in three different groups: young, old and PD. We assessed corticomuscular coherence during the gait 
cycle in both gait modalities as well as other spectral measures that have previously been investigated during 
gait59,80,90–93. If the changes in gait observed with ageing and/or PD reflect, at least in part, deficient cortical control 
due to neurodegeneration in the brain, we expect that corticomuscular coherence will be affected in the older 
and PD groups and may be differently modulated by overground and treadmill gait. By investigating functional 
interactions between brain and muscle we aim to contribute to a better understanding of the changes in cortical 
control of gait with ageing and PD.
Results
We investigated corticomuscular activity and coupling in 24 healthy young adults, 24 healthy older adults and 21 
individuals with PD, while participants walked at their preferred speed and EEG from 10 cortical sites and EMG 
from the tibialis anterior (TA) muscles were recorded. In particular, we compared changes in spectral power, 
inter-trial coherence (ITC) and corticomuscular coherence (CMC) at two bipolar derivatives over bilateral sen-
sorimotor cortices between groups to investigate changes in the neural control of gait with ageing and PD. In 
addition, temporal gait parameters were calculated from footswitch recordings.
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In the young and PD groups, data of some participants were excluded from the spectral analysis (two from 
healthy young group, one from PD overground, three from PD treadmill) due to either excessive EEG arte-
facts across all channels and conditions (large-amplitude movement artefacts (>300 µV) occurring with regular 
rhythmicity in each gait cycle throughout the entire record), or due to problems with the footswitch recordings 
(fewer than 100 heel strike triggers). Hence, spectral measures, demographics, clinical and gait assessments were 
based on n = 22 for the younger group, n = 24 for the older group, and n = 20 for PD group (n = 18 for spectral 
measures during treadmill walking). In addition, some data were missing for particular outcome measures: in the 
older group data of one participant were missing for body weight, visual function, and tactile sensitivity (n = 23 
for these measures); in the PD group data of one participant were missing for the Bailey Lovie – low contrast 
sensitivity vision test (n = 19 for this measure).
Group characteristics. The mean (SD) age of healthy young participants was 25.9 (3.2) years, they had 
a body height of 170.4 (9.5) cm, and body weight of 68.8 (12.1) kg; 50% were male. Participants in the old and 
PD groups were of similar age (old: 65.1 (7.8) years, PD: 67.4 (7.3) years), height (old: 169.2 (8.2) cm, PD: 170.3 
(9.2) cm), weight (old: 75.2 (14.2) kg, PD: 74.9 (14.8) kg) and gender balance (50% male in the older and 60% 
in the PD group). PD participants were in the early stages of the disease (Hoehn & Yahr score 1.3) and had an 
average MDS-UPDRS score of 38.8, indicating a mild to moderate disease severity. The results of the Gait & Falls 
Questionnaire (GFQ) demonstrated that the PD participants experience only mild gait impairments (Table 1).
The PD and healthy older control group had similar levels of cognitive function, no cognitive decline, and all 
were well above recognised cut-offs for dementia94. Both groups had similar levels of tactile sensitivity on the soles 
of their feet (Table 2). Tactile sensitivity was measured using a Semmes-Weinstein pressure aesthesiometer, which 
contained eight nylon monofilaments corresponding to eight thresholds95. High and low contrast visual acuity 
as well as contrast sensitivity (Pelli Robson; Melbourne Edge Test) were impaired in people with PD compared 
to controls (p ≤ 0.03). The Activities-specific Balance Confidence (ABC) scale showed that healthy older peo-
ple had more confidence undertaking activities without falling than people with PD (p < 0.04); the Ambulatory 
Self-Confidence Questionnaire (ASCQ) showed a similar trend but the group difference was not statistically 
significant (p = 0.07). It is worth noting that the ABC and ASCQ scores were also more variable for the PD than 
for the older group.
Temporal gait parameters. Most temporal gait parameters were similar for all groups (p ≥ 0.09) (Table 3). 
The duration of swing and single support was significantly different between groups (F2, 63 = 3.64, p = 0.03). 
Healthy older people had a significantly shorter swing and single support phase than healthy young people 
(p = 0.016), and so did people with PD (p = 0.027). There was no significant difference in swing or single support 
time between healthy older people and people with PD (p = 0.91). The main effect of condition (overground vs 
treadmill walking across all participants) for all gait parameters is presented in Table S1 in the Supplementary 
Material. Stride time, step time, stance phase and swing/single support phase were significantly shorter during 
treadmill compared to overground walking.
Time-frequency power and coherence spectra. Event-related changes in time-frequency power and 
coherence within the gait cycle were assessed to investigate differences in neural control of gait between groups. 
This included estimates of five spectral measures using time-frequency decomposition: EEG and EMG power, 
inter-trial coherence of EMG and EEG, and corticomuscular coherence. These spectral estimates revealed a con-
sistent pattern across groups: Power and coherence increased across a range of frequencies during double support 
and was reduced during the swing and single support phases. Figure 1 shows examples of time-frequency spectra 
of the right sensorimotor cortex and EMG from the left TA during overground walking in young, older and peo-
ple with PD.
The averaged power and coherence across the double-support phase (0–125 ms after heel strike) are shown 
in Fig. 2. Most of the power and coherence during the double-support phase was observed at low frequencies 
and decreased at higher frequencies. In addition, a peak around 16 Hz can be observed in EEG power and 
inter-trial coherence, which is most prominent in the young group. A peak in the low beta band (13–21 Hz) can 
also be observed in EMG power, inter-trial coherence and corticomuscular coherence, although these are less 
pronounced.
The spectral measures were statistically compared between groups for five frequency bands (theta, alpha, 
low beta, high beta and gamma) using linear mixed models (LMMs) and the false discovery rate was controlled 
using the Benjamini-Hochberg procedure96,97. Table 4 reports the main effect of group for all spectral measures; 
Supplementary Figs. S2 and S3 present these statistical results separately for overground and treadmill walking. 
Several significant main effects of group were observed during double support: EMG power at all frequency 
Measure Mean SD N
MDS-UPDRS total 38.8 13.9 20
MDS-UPDRS motor 18.8 7.3 20
Hoehn & Yahr 1.3 0.5 20
LEDD (mg) 544 241 20
GFQ 4.3 4.0 19
Table 1. Clinical characteristics of PD group. Abbreviations: GFQ, Gait & Falls Questionnaire; LEDD, levodopa 
equivalent daily doses; MDS-UPDRS, Movement Disorders Society Unified Parkinson’s Disease Rating Scale.
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windows (padj < 0.02); EMG inter-trial coherence at theta frequencies (padj = 0.025); corticomuscular coherence 
at low beta frequencies (padj = 0.013). Similarly, several significant main effects of condition (overground, tread-
mill) were found (see Supplementary Table S4) whereby magnitudes were reduced for treadmill walking: EEG 
power at theta, high beta and low gamma frequencies; EMG power across all frequency windows; EMG inter-trial 
coherence at high beta and gamma frequencies; corticomuscular coherence at high beta and gamma frequencies.
Post-hoc tests of significant group main effects revealed significant differences in EMG power and low-beta 
corticomuscular coherence between the young group and the old and PD groups but not between the old and PD 
groups (see Fig. 3 and Table S5). In contrast, inter-trial coherence in the theta band was different between young 
and PD, as well as old and PD, but not between the young and old groups. Effect sizes (Cohen’s ds) of pairwise 
group comparisons are shown in Table S6.
EMG envelopes. To further explore the group differences observed in spectral measures of EMG, the 
event-related EMG envelopes were analysed in the time domain. EMG envelopes revealed two bursts of activity 
during early swing and around heel strike (Fig. 4). The second increase in EMG activity is marked by a double 
peak (at heel strike (t = 0) when the foot is fully dorsiflexed and at 60 ms after heel strike). Notably, the EMG 
amplitude was larger in older people and people with PD during early swing, and the second peak during the 
double support phase appeared to be reduced in the PD group. To statistically test this, we ran a LMM on the 
average EMG amplitude between −0.4 to −0.25 s (foot lift) and between 0.04 to 0.08 s (foot drop) relative to heel 
Measure
Healthy old 
(n = 24) PD (n = 20) Group effect
Mean SD Mean SD t-value p-value
Demographics
Age (years) 65.1 7.8 67.4 7.3 −1.01 0.32
Sex (female, count) 12 8
Height (cm) 169.2 8.2 170.3 9.2 −0.42 0.68
Weight (kg) 75.2 14.2 74.9 14.8 0.06 0.95
Balance and gait self-confidence
ABC 94.5 5.5 89.4 10.1 2.14 0.038
ASCQ 9.56 0.58 9.06 1.17 1.83 0.07
Cognitive function
ACE-R 94.2 3.8 91.2 6.1 2.01 0.051
MMSE 28.9 1.2 28.8 1.5 0.18 0.86
Vision
Bailey Lovie – high 0.03 0.08 0.15 0.17 −3.2 0.003
Bailey Lovie – low 0.38 0.14 0.53 0.19 −2.87 0.007
Pelli Robson 1.92 0.13 1.82 0.18 2.21 0.03
Melbourne Edge Test 18.5 1.4 17.5 1.9 2.01 0.051
Tactile sensitivity (threshold 1 to 8)
Ankle 4.02 0.78 4.63 1.23 −1.95 0.059
Toe 3.39 1.11 3.55 0.94 −0.50 0.62
Medial plantar 3.63 1.51 3.83 1.54 −0.42 0.68
Heel 5.41 1.11 5.05 1.70 0.84 0.41
Total 4.11 0.85 4.26 1.12 −0.49 0.63
Table 2. Demographics and clinical characteristics of healthy older and PD groups. Abbreviations: ABC, 
Activities-specific Balance Confidence; ACE-R, Addenbrookes Cognitive Examination Revised; ASCQ, 
Ambulatory Self-Confidence Questionnaire; MMSE, Mini Mental State Exam; PD, Parkinson’s disease.
Gait parameter
Healthy young Healthy old PD Group effect
mean SEM mean SEM mean SEM F P
Walking speed (km/h) 4.16 0.12 4.00 0.11 3.97 0.12 0.84 0.44
Stride time (s) 1.10 0.02 1.09 0.01 1.06 0.02 1.45 0.24
Stride time variability (s) 0.020 0.002 0.019 0.002 0.021 0.002 0.46 0.64
Step time (s) 0.548 0.008 0.541 0.008 0.522 0.009 2.48 0.09
Step time variability (s) 0.012 0.002 0.010 0.002 0.012 0.002 0.35 0.71
Stance phase (s) 0.689 0.013 0.696 0.012 0.674 0.014 0.74 0.48
Swing phase/Single support (s) 0.404 0.007 0.381 0.006 0.382 0.007 3.79 0.03
Double support (s) 0.146 0.010 0.156 0.010 0.160 0.011 0.53 0.59
Table 3. Temporal Gait Parameters in healthy young, healthy older and PD groups.
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Figure 1. Grand-average time-frequency spectra of EEG power, inter-trial coherence and corticomuscular 
coherence. Event-related EEG power (EEG Pow, top row), inter-trial coherence of EEG (ITC EEG, middle 
row) and corticomuscular coherence (CMC, bottom row) acquired from bipolar EEG signals of the right 
sensorimotor cortex (C4-F4) and EMG from the left TA during overground walking in the young, old and 
PD groups. EEG power shows the percent change from the average. Coherence values (ITC and CMC) are 
thresholded: average coherence values below the 95% CI are set to zero (white). The x-axis shows the time in 
seconds relative to heel strike (t = 0) of the left foot and the y-axis the frequencies in Hz. Black vertical lines 
indicate the footswitch events. LHS, left heel strike; LTO, left toe-off; RHS, right heel strike; RTO, right toe-off.
Figure 2. Grand-average frequency spectra during double support. Spectral measures averaged over double 
support for each group (young, old, PD): EEG power (first column), EMG power (second column), inter-trial 
coherence of EEG (ITC EEG, third column), inter-trial coherence of EMG (ITC EMG, forth column) and 
corticomuscular coherence (CMC, fifth column) during overground (top row) and treadmill (bottom row) 
walking. Data derived from bipolar EEG signals of the right sensorimotor cortex (C3-F3) and EMG from the 
left TA. X-axis shows frequencies in Hz; grey vertical lines highlight the different frequency bands and the 
dashed horizontal line the 95% CI of the coherence estimates.
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strike. EMG amplitude at foot lift was significantly different between groups (F2, 63 = 17.81, p < 0.0001), but not at 
foot drop (F2, 63 = 2.12, p = 0.13). Healthy older people had a significantly larger EMG amplitude during foot lift 
(67.3% [95%CI 62.6, 72.0]) than healthy young people (47.6% [95%CI 42.8, 52.5], p < 0.0001), and so did people 
with PD (61.9% [95%CI 56.7%, 67.0], p = 0.0001). There was no significant difference in EMG amplitude at foot 
lift between healthy older people and people with PD (p = 0.12). While no significant group effect was found 
during foot drop, we noticed considerable variability between participants in each group (Fig. 5). For example, 
in the PD group EMG amplitude during foot drop varied almost between 5–90% relative to the maximum EMG 
amplitude within the gait cycle. The results of the main effect of condition are shown in Table S7, showing that the 
EMG amplitude during foot drop is lower during treadmill compared to overground walking.
The EMG amplitude during both time intervals was correlated with corticomuscular coherence in the lower 
beta band during the double support phase within each of the groups (young, old and PD) and conditions (tread-
mill and overground). None of the correlations were significant when testing each group separately (p > 0.05). 
EMG amplitude during foot lift appears to be negatively correlated with corticomuscular coherence (Fig. 5, left 
panels), but this is mainly due to the group effects in which the young group shows lower EMG amplitude during 
foot lift and higher corticomuscular coherence during double support.
Discussion
We performed time-frequency analysis of electrophysiological data recorded during overground and treadmill 
walking in healthy young, healthy older and people with PD to investigate changes in cortical and corticospinal 
processes during walking. PD participants were in early stages of the disease with mild to moderate symptom 
severity, without freezing of gait or frequent falls and were optimally medicated for all assessments. All three 
groups showed significant corticomuscular coherence at theta, alpha, beta and gamma frequencies (4–45 Hz) 
between the sensorimotor cortex and the contralateral TA muscle during the double support phase that was 
largely absent during the swing phase. Similarly, power and inter-trial coherence also increased during dou-
ble support. Older participants and people with PD showed significantly reduced corticomuscular coherence at 
low beta frequencies (13–21 Hz) compared to young individuals, but there was no difference between healthy 
older and people with PD. EMG power was significantly decreased in all frequency bands in healthy older and 
Spectral 
measure
Healthy young Healthy old PD Group effect
mean 95% CI mean 95% CI mean 95% CI F P Padjusted
EEG power (%)
Theta 21.7 14.4–29.0 23.6 16.6–30.56 16.1 8.3–23.9 1.05 0.36 0.50
Alpha 24.9 17.4–32.4 21.7 14.5–28.91 17.6 9.7–25.6 0.89 0.42 0.51
Low beta 33.2 25.2–41.2 20.0 12.4–27.68 19.7 11.2–28.2 3.71 0.030 0.075
High beta 20.6 13.2–28.1 15.8 8.7–22.94 18.9 11.0–26.9 0.45 0.64 0.67
Gamma 15.5 10.0–21.0 11.8 6.6–17.05 19.9 14.0–25.7 2.09 0.13 0.22
EMG power (log)
Theta 9.9 9.7–10.1 9.5 9.4–9.72 9.4 9.1–9.6 8.22 0.001 0.013
Alpha 9.1 8.9–9.2 8.7 8.6–8.9 8.6 8.4–8.8 5.86 0.005 0.021
Low beta 8.8 8.6–9.0 8.4 8.3–8.61 8.3 8.1–8.5 7.45 0.002 0.013
High beta 8.4 8.2–8.6 8.1 7.9–8.26 7.9 7.8–8.1 6.77 0.002 0.013
Gamma 8.0 7.9–8.2 7.8 7.7–7.98 7.6 7.4–7.8 6.16 0.004 0.020
ITC EEG (z-score)
Theta 12.5 11.1–13.8 13.0 11.7–14.29 12.3 10.8–13.8 0.28 0.76 0.76
Alpha 10.2 8.9–11.6 10.1 8.8–11.41 9.2 7.7–10.7 0.64 0.53 0.58
Low beta 11.1 9.7–12.6 9.1 7.7–10.49 8.1 6.6–9.7 4.20 0.019 0.060
High beta 8.7 7.2–10.1 7.6 6.2–8.97 7.2 5.6–8.7 1.10 0.34 0.50
Gamma 6.1 5.0–7.3 5.2 4.1–6.35 5.9 4.6–7.1 0.66 0.52 0.58
ITC EMG (z-score)
Theta 24.6 22.8–26.4 23.0 21.3–24.8 20.3 18.4–22.2 5.36 0.007 0.025
Alpha 15.9 14.5–17.4 14.5 13.0–15.88 13.0 11.5–14.6 3.60 0.033 0.075
Low beta 11.7 10.5–12.8 9.7 8.6–10.82 10.3 9.1–11.5 2.99 0.057 0.11
High beta 6.9 5.8–8.0 5.4 4.3–6.45 5.5 4.4–6.7 2.29 0.11 0.20
Gamma 3.6 2.9–4.4 3.0 2.3–3.68 3.1 2.3–3.9 0.89 0.42 0.51
CMC (z-score)
Theta 8.7 7.7–9.8 8.4 7.4–9.45 7.44 6.3–8.6 1.53 0.23 0.36
Alpha 5.1 4.4–5.9 4.4 3.7–5.16 3.75 2.9–4.6 3.02 0.056 0.11
Low beta 4.1 3.5–4.7 2.7 2.1–3.22 2.72 2.1–3.3 7.82 0.001 0.013
High beta 2.0 1.5–2.4 1.2 0.8–1.6 1.30 0.8–1.8 3.89 0.026 0.072
Gamma 0.9 0.7–1.1 0.7 0.5–0.9 0.74 0.5–1.0 0.87 0.43 0.51
Table 4. Main effect of group for spectral measures and mean estimates with 95% confidence intervals. CI, 
confidence interval; ITC, inter-trial coherence; CMC, corticomuscular coherence.
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PD participants compared to the healthy young group. Interestingly, walking speed, stride time and its variabil-
ity, and the duration of the double support phase was similar across all groups. However, people with PD and 
healthy older people spent significantly shorter time in single support and swing phases of gait than healthy 
Figure 3. Spectral measures that reveal significant main effect of group. Spectral measures were averaged 
over double support in different frequency bands for each group (young, old, PD). EMG power at low beta 
frequencies (EMG pow, first column), EMG inter-trial coherence at theta frequencies (ITC EMG, second 
column), corticomuscular coherence at low beta frequencies (CMC, third column) during overground (top 
row) and treadmill (bottom row) walking. Data derived from bipolar EEG signals of the right sensorimotor 
cortex (C3-F3) and EMG from the left TA. Coloured dots show individual data of each participant, black 
horizontal lines show the group mean, grey boxes show the SEM.
Figure 4. Grand-average EMG envelopes. EMG envelopes of the left and right tibialis anterior (TA) during 
overground and treadmill walking in the young, old and PD groups. The x-axis shows time relative to heel 
strike (t = 0) and the y-axis the amplitude relative to the maximum within the gait cycle. Dashed lines show the 
kinematic events (lhs, left heel strike; lto, left toe-off; rhs, right heel strike; rto, right toe-off).
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young people. The amplitude of the TA EMG envelope during early swing was significantly larger in older people 
and people with PD compared with healthy young participants. Hence, the current findings reveal age-related 
changes in the corticomuscular control of walking. They further indicate that corticomuscular control in people 
with early-stage PD and low to moderate disease severity while under optimal medication is similar to that of 
older people. Task-dependent differences in neural control of locomotion are also suggested by temporal gait and 
frequency-dependent differences between overground and treadmill walking.
Changes in corticomuscular control with aging and Parkinson’s disease. We observed several 
differences in electrophysiological and gait measures between young and old participants, as well as young and 
PD participants, but not between the old and PD groups. A primary outcome was reduced corticomuscular 
coherence at low beta frequencies during double support for older and PD participants compared to young par-
ticipants. This indicates that reduced functional connectivity in corticospinal pathways involved in gait control 
is primarily affected by age. Several previous studies also found reduced corticomuscular coherence in older 
compared to younger adults. Spedden et al.98 reported attenuated corticomuscular coherence during treadmill 
walking in older compared to young participants. Yoshida and colleagues82,83 found decreased corticomuscular 
coherence during rhythmic ankle movements in older people compared to young adults but not between older 
and PD participants, and Ozdemir et al.99 found reduced corticomuscular coherence for the TA muscle during 
perturbed standing in older compared to young people. Studies on upper limb muscles during sustained con-
tractions also found reduced corticomuscular coherence in older people85,86. However, other studies on fore-
arm and finger contractions found increased corticomuscular coherence in older adults84,100, which may reflect 
task-specific requirements (visual feedback, dual-tasking). In people with PD, corticomuscular coherence during 
tonic forearm contractions was also not found to be different compared to healthy age-matched controls87,88, and 
may87 or may not88,101 be modulated by levodopa medication. As PD participants in this study had a low to mod-
erate disease severity, similar levels of cognitive function, tactile sensitivity and gait as their healthy age-matched 
counterparts, and they completed the experiments on medication, this may explain why we did not observe a 
difference in corticomuscular coherence between PD and age-matched controls.
We did not find a significant group effect for EEG power and EEG inter-trial coherence, at least not after con-
trolling the false discovery rate (see Table 4). However, the direction of the observed differences between groups 
was still similar to the changes in corticomuscular coherence, especially at low beta frequencies (see Fig. 2). This 
may imply that a group difference was present but that the effect size was too small to detect it with the current 
sample size. Possibly, measures based on EEG alone are less sensitive (higher inter-subject variability) than meas-
ures based on EEG and EMG (i.e. corticomuscular coherence). Previous studies have documented changes in 
cortical oscillatory activity with age and PD mainly during fine motor tasks of the upper limbs and at rest63,102–106. 
During walking, EEG gamma power over frontal cortices was enhanced in older people during dual-task walk-
ing compared to young controls59. During upright standing, cortical activity was altered in older people99,107,108. 
In people with PD, increased theta and low-gamma cortical power was associated with freezing of gait during 
turning compared to normal fluent turning60,61. However, whether cortical oscillations during walking are truly 
affected by age or PD remains to be shown in larger future studies.
In addition to the changes in the corticomuscular coherence results, we also found reduced EMG power 
during double support in older and PD participants compared to young participants. Again, no significant dif-
ferences were observed between the older and PD groups. Previous studies reported a number of age-related 
Figure 5. Relationship between EMG amplitude and corticomuscular coherence. EMG amplitude was averaged 
in two time intervals (foot lift: −0.4 to −0.25 s; foot drop: 0.04 to 0.08 s for each group (young, old, PD) and 
condition (overground and treadmill). The bar graphs show the summary statistics in each group and the scatter 
plots the relationship with corticomuscular coherence (CMC) in the lower beta band. Coloured dots show 
individual data of each participant, black horizontal lines show the group mean, grey boxes show the SEM.
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changes in EMG activity during walking indicating that recruitment of ankle muscles changes with age. For 
example, EMG magnitude of the TA at mid swing was shown to decrease with age109, and the onset of TA activity 
within the gait cycle was earlier and offset was later in older compared to young adults110,111. In PD, EMG activity 
of distal leg muscles during gait was found to be reduced and poorly modulated112–115. As motor units undergo 
several morphological and physiological adaptations with ageing, this also affects their discharge behaviour116. 
For instance, motor unit firing rates decrease with age117–119 and show greater variability120. We also found a sig-
nificant difference in inter-trial coherence of the EMG signal at theta frequencies between groups, but unlike the 
other outcome measures it was reduced in people with PD compared to young and old controls (Table S5). This 
suggests reduced phase-locking of the EMG envelopes with respect to heel strike, at least at theta frequencies, and 
may indicate more variable muscle activation patterns across gait cycles in people with PD.
Although EMG power was reduced during the double-support phase, we did not find a concomitant reduc-
tion in EMG amplitude in the time domain (see Fig. 4). This may be partly due to the way EMG amplitude was 
normalised121. However, EMG envelope amplitude was significantly increased during early swing in older and PD 
compared to young people. Although the temporal profiles of the EMG envelopes in the present study are consist-
ent with previous reports113,122–126, the direction of reported changes in EMG amplitude with age are only partially 
consistent. For example, some studies found increased EMG amplitude in older people during treadmill125 and 
overground walking126 at different speeds (in agreement with our study), while other studies reported a reduction 
in EMG amplitude with age during overground walking124. Likewise, age-related changes in EMG amplitude 
have been found in different parts of the gait cycle, e.g. at mid swing124, mid stance126, and terminal stance124. 
This may be due to differences in experimental designs (e.g. number and duration of walking trials and speeds), 
and due to data processing techniques (e.g. how EMG signals were normalised). Notably, we found the TA EMG 
amplitude during foot drop reduced during treadmill compared to overground walking in all subjects, which is 
in agreement with previous reports of lower TA activation during the load phase of the gait cycle in people with 
and without PD33.
Older and PD participants spent shorter time in swing and single support than young individuals indicating 
age-related changes in motor performance. This is consistent with previous reports of kinematic and kinetic 
changes of gait in older people9,11. Previous studies have also documented differences in gait between people 
with PD and healthy age-matched controls1,12–16,112–114, which we did not observe in the current study. However, 
previous studies mainly detected PD-related gait differences by kinetic, kinematic, spatial and muscle activation 
parameters but less consistently in temporal gait parameters, which were assessed in the current study. Although 
we did not find any differences in gait performance between people with PD and their healthy age-matched 
controls, we found differences in gait performance as well as in a number of spectral outcome measures and 
EMG envelopes between overground and treadmill walking. Treadmill walking reduced the duration of stride 
and step time, stance and swing phase, and the amplitude of the TA EMG at foot drop. The backward movement 
of the treadmill belt may shorten the time between heel strike and forefoot drop, which is largely controlled by 
the dorsiflexors and ensures body weight support during the early load phase33,127,128. Multiple spectral measures 
also showed reduced magnitudes during treadmill walking, in particular EEG and EMG power, EMG inter-trial 
coherence and corticomuscular coherence at high beta and low gamma frequencies. These differences in power 
and coherence may reflect changes in gait stability129, step adaptations130 or sensorimotor processing91 related to 
controlling foot drop80. Possibly, these mechanisms help to explain improvements in gait in people with PD after 
treadmill training30,32–34.
In summary, there were several age-related changes in physiological and temporal gait variables during over-
ground and treadmill walking, but little or no differences between the older and PD groups. It is possible that the 
lack of group differences between older and PD participants in our study is due to characteristics of our particular 
PD sample (low to moderate disease severity, similar levels of cognitive function and tactile sensitivity as healthy 
controls, optimally medicated) or due to low statistical power of this study. The effect size estimates for the old-PD 
comparisons were mostly negative and on average |0.24|. It is hence possible that small differences exist between 
people with PD and age-matched controls which cannot be detected with the current sample size. The effect sizes 
for the comparison of the young and old groups were also mostly negative and many were larger than |−0.5|; the 
young-PD comparison effect sizes showed a similar trend with even larger values and a number of them reaching 
approximately |−1|. While these are rather large effect sizes, this should be interpreted with caution as effect sizes 
are often overestimated in small samples131. Indeed, the confidence intervals we report indicate that the true pop-
ulation effect sizes may be much smaller.
Physiology of low beta oscillations. During the double support phase, the frequency spectra showed 
a gradual reduction in power and coherence at higher frequencies with a superimposed peak in the lower beta 
range (see Fig. 2). The peak in the beta band was more pronounced in the EEG measures (EEG power and 
inter-trial coherence) than in the EMG measures. In this frequency band we also found a significant group effect 
for corticomuscular coherence and EMG power. The other outcome measures show a similar pattern in the low 
beta band (highest in young, decreased in older and PD participants; Fig. 2), although these did not reach statisti-
cal significance in the group comparison. Notably, the effect size estimates in the low beta band were consistently 
negative across all outcome measures and largest for corticomuscular coherence and EMG power.
Oscillatory activity at beta frequencies has been identified as an important feature in motor control. Many 
studies have shown that beta band activity is enhanced during tonic contractions and diminished during dynamic 
voluntary movement132–138, and can be observed at different levels of the central nervous system including motor 
cortex, basal ganglia and motor units in the periphery62,132. Recently it was shown that movement-related modu-
lations of beta oscillatory activity occur in brief bursts rather than as an ongoing rhythm139,140. Beta band activity 
is thought to reflect a mechanism involved in maintaining the current sensorimotor state67,132,141. During walking, 
beta oscillations have been found to be task-dependent and a number of interpretations have been put forward. 
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For instance, cortical beta oscillations may be related to controlling gait stability129,142, control of step lengthening 
and shortening adaptations130,143, visuomotor integration144–146, speed control147,148, forward propulsion driven 
by ankle plantar flexors149, erroneous anticipatory postural adjustments during gait initiation150, and responding 
to sensorimotor conflict during perturbations while walking151. An interesting hypothesis is that activity in the 
beta band may underpin the temporal coordination of sensorimotor processes152–154, and hence be involved in the 
temporal coordination of the heel strike during walking.
In PD, it is well established that beta activity in the basal ganglia is enhanced at rest in the dopamine-depleted 
state and can be restored to normal levels with levodopa medication63,64,155,156. This exaggerated pathophysio-
logical beta activity in the basal ganglia has been found associated with bradykinesia and impaired motor func-
tion62–64,66,157. Interestingly, walking and cycling has been found to modulate/normalise beta activity in the 
subthalamic nucleus (STN) in people with PD73–75. Walking and cycling was found to decrease STN beta power in 
people with PD73. Stepping movements were found to modulate STN beta power relative to the movement cycle, 
and these modulations were associated with stepping performance74. Patterns of STN beta oscillations (i.e. dura-
tion of beta bursts) were also found to be linked to freezing of gait158. A number of studies that investigated cor-
tical oscillatory activity during upper limb movements reported beta frequencies to be affected by PD88,101,159–161. 
For instance, cortical beta power during static forearm contractions was increased in people with PD compared 
with healthy controls88, although others reported it to be decreased159,161.
We only observed a reduction in low beta corticomuscular coherence during the double support phase. The 
duration of the double support phase is about 125 ms and fits about 2 cycles of beta oscillations. Hence, these 
results likely reflect reduced bursts of beta oscillations rather than changes in ongoing beta oscillations162,163. 
These beta bursts may represent brief activity reflecting the retrospective evaluation of task performance and 
updating subsequent task performance139. In the present context, error-related activity may reflect the temporal 
parameters of step cycles. We found a parallel increase in power and inter-trial coherence, which suggests that 
transient beta activity likely represents an evoked response rather than true synchronisation of two interacting 
oscillators80. As we observe coherent beta activity at the cortical and spinal level, it is possible that these beta 
bursts are transmitted via the corticospinal tract or that subcortical or spinal networks simultaneously evoke 
time-locked responses at the cortical and spinal level. As such, the decreased low beta corticomuscular coher-
ence in older and PD groups found in this study may reflect an attenuated evoked response at cortical and/or 
spinal levels. At the spinal level, differences in evoked TA responses may reflect reduced activity of dorsal horn 
spinal neurons164,165, which receive input from Ia afferents that are known to degenerate with age. During upright 
standing, for example, age-related degeneration of Ia afferents has been shown to affect leg muscle activity and to 
contribute to impaired postural control performance166.
Limitations. The current study is exploratory in nature involving five different outcome measures in five 
frequency bands (resulting in 25 statistical comparisons). With a limited samples size (about 20 per group) the 
statistical power is fairly low and results should be interpreted cautiously. We did control the false discovery rate 
using the Benjamini-Hochberg procedure (see adjusted p-values in Table 4). Still, future studies (that are ideally 
pre-registered)167 will need to confirm these findings by specifically testing in the lower beta band, which will 
increase statistical power. To facilitate appropriate power calculations for future studies, we have reported effect 
sizes and uploaded all outcomes measures to Figshare.
Another limitation is that PD participants completed all experiments in an optimally medicated state and 
we therefore cannot address potential medication effects on gait and cortical/corticospinal oscillatory activity in 
people with PD. Past studies reported inconsistent and contradictory findings with respect to medication effects 
on cortical and corticospinal oscillations at rest and during movement in people with PD. For instance, Salenius et 
al.87 reported a levodopa effect on beta corticomuscular coherence during isometric forearm contractions, while 
Pollok et al.88 and Hirschmann et al.101 did not. Notably, Yoshida and colleagues82,83 found decreased corticomus-
cular coherence in older people compared to young adults during rhythmic ankle movements but not between 
older and PD participants (similar to our results) when tested their PD participants in an ‘off-medication state’ 
(after overnight withdrawal). This creates uncertainty with regards to potential medication effects on cortical and 
corticospinal oscillatory activity during walking in people with PD, and it is possible that we did not find differ-
ences between the PD and age-matched control group because the PD group was assessed in an on-medication 
state. Another potential explanation may be the characteristics of our particular PD sample (low disease severity, 
cognitive function, tactile sensitivity, ‘agility’), indicating that our PD sample may not have been very different 
from the healthy older cohort. Moreover, the experimental paradigm itself was not very challenging (simple 
steady-state walking) and may therefore not be able to distinguish minor deficiencies in corticomuscular control 
in this relatively agile sample. More challenging paradigms including dual-task walking or perturbations that 
trigger deliberate stepping adaptations (for example, similar to Malcolm et al.57) may be better suited to detect 
changes in cortical and corticospinal oscillatory activity during the early stages of PD.
Finally, mobile EEG is susceptible to movement artefacts and caution should hence be exerted when inter-
preting phasic changes in EEG activity168–175. In this study, we applied multiple strategies to minimize the effects 
of motion artefacts according to standards currently established in this research field. We excluded gait cycles 
with excessive artefacts, we performed ICA, and we calculated a bipolar derivative EEG signal80. Artefact sep-
aration using ICA is dependent on the number of channels recorded and performs best with high-density 
recordings, while its performance may be impaired with a low number of channels176. In fact, the effect of the 
number of channels on artefact identification performance in all component-based methods like ICA is a matter 
of ongoing debate177. The limited number of EEG channels recorded in this study may have compromised the 
separation of artefact sources and led to mixing of brain and artefact sources. Notably, the timing of power and 
coherence changes in artefact contaminated data (Figs. S9–S11) is similar to the time-frequency profiles in the 
pre-processed artefact-cleaned data in Fig. 1 and in Figs. S12–S14 (Supplementary Material). This highlights 
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that the results presented herein cannot be assumed to be completely artefact-free and that a cautious inter-
pretation is warranted. However, even acquisition of a larger number of EEG channels cannot guarantee that 
EEG signals will be artefact free169. We also explored the effects of different pre-processing and artefact removal 
techniques (such as artefact subspace reconstruction177 [ASR] and adaptive mixture ICA178,179 [AMICA]) on the 
time-frequency results, which are presented in the Supplementary Material. Importantly, pre-processing using 
ICA, ASR or AMICA yielded qualitatively similar results, which indicates that the presented results are robust for 
different pre-processing procedures (i.e. not dependent on the particular pre-processing algorithm used). Finally, 
we also pre-processed the EMG recordings by high-pass filtering, rectifying, and demodulating the signals in 
order to remove low-frequency artefacts and periodic amplitude modulations that could distort the coherence 
estimates180,181. Previous studies found that low delta and high gamma oscillatory activity may be more affected 
by movement artefacts than other frequency bands168. Notably, the time-frequency profiles observed in this study 
are similar to those in multiple previous ambulatory EEG studies80,81,90,129,147,182–185. This suggests that the observed 
time-frequency profiles in the current and previous studies reflect neural activity, or alternatively, are all affected 
in a similar way by movement artefacts. Importantly, in the current study we found a significant group effect for 
corticomuscular coherence specifically at lower beta frequencies, but not over a broadband frequency range. It 
seems unlikely that these frequency-specific changes are caused by non-physiologic artefacts. However, mobile 
EEG recordings remain challenging and novel methods to reduce movement artefact contamination (e.g. ASR186 
or dual-electrode arrays187) are constantly being developed170,188. Further research is hence needed to confirm the 
here-reported reduction in low beta corticomuscular coherence in older participants.
conclusion
This study shows coherent corticomuscular activity during the double support phase of the gait cycle during 
steady-state overground and treadmill walking in healthy young and older adults, as well as people with PD. We 
found that low beta corticomuscular coherence and EMG power was decreased in older and PD participants 
compared to young people, and that it was not different between older and PD participants, suggesting that these 
alterations in corticomuscular control of gait were mainly age-related. Furthermore, task-dependent differences 
in neural control of locomotion were also suggested by frequency-dependent differences between overground 
and treadmill walking. Transient and concomitant increases in power and inter-trial coherence suggest evoked 
bursts of beta activity at spinal and cortical populations rather than a modulation of ongoing corticospinal beta 
synchronization. The reduction of transient beta activity may reflect changes in the temporal coordination of 
motor events within the gait cycle such as the timing of foot drop. Observed group differences in several electro-
physiological and temporal gait measures indicate inter-related control mechanisms at the peripheral, spinal and 
cortical levels. However, as we did not observe any correlations between corticomuscular coherence and EMG 
amplitude (see Fig. 5), this suggests that ageing- and PD-related changes are multi-factorial, i.e. affect different 
systems, including the cortex, spine and periphery. These results should be interpreted with caution as they can-
not be assumed to be completely artefact-free, and will need to be confirmed in future research.
Materials and Methods
Three groups participated in the study with 69 participants in total: (1) 24 healthy young adults, (2) 24 healthy 
older adults, (3) 21 individuals with PD. All experimental protocols were approved by the Human Research 
Ethics Committee of Queensland University of Technology (#1300000579) in accordance with the Declaration of 
Helsinki, and all participants gave written informed consent prior to participation. The results of the young adults 
have been previously described in Roeder et al.80.
Experimental protocol. Participants performed overground walking for 12–14 minutes and treadmill 
walking for approximately seven minutes. Participants walked barefoot at their preferred speed (3.3–4.8 km h−1), 
which was matched across conditions on an individual basis. During both conditions, participants walked with 
their hands free (natural arm swing). In the overground condition, participants walked back and forth along a 
straight path (~14 m) on a firm surface in the gait laboratory and turned at each end of the room. The turning sec-
tions, including acceleration at the beginning of the straight-line path and deceleration at the end (~2.4 m), were 
excluded from further analyses and only straight-line walking (8.9 m) was used for further analysis. The order 
of treadmill and overground walking was randomised across participants, and participants rested for 5 minutes 
between both walking conditions. Before the actual gait experiments commenced, participants completed a test 
trial (overground) of approximately three minutes in order to determine their preferred walking speed. Their 
mean walking velocity during the test trial was used to set the treadmill belt speed and to monitor and maintain 
the participants’ walking speed during the overground condition. If the participant did not comply with the 
pre-determined mean walking speed during the overground condition, they were instructed to walk faster/slower.
Healthy older people and people with PD also completed the following tests on a day other than 
the walking experiments within a 6-week period: Addenbrooke’s Cognitive Examination (ACE-R) and 
Mini-Mental-State-Exam (MMSE)94,189, visual function tests (Bailey Lovie, Melbourne Edge Test, Pelli 
Robson)190–192, and a peripheral sensation test assessing tactile sensitivity at different sites of their feet (lateral 
malleolus, plantar surfaces of the great toe, midfoot/arch and heel) using Semmes-Weinstein pressure aesthesi-
ometer with nylon monofilaments95. Moreover, participants completed a number of health-related questionnaires 
including the ABC scale193, ASCQ194, and Edinburgh Handedness Inventory195. Additionally, people with PD 
were assessed for disease severity using the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Hoehn 
& Yahr scoring196,197, and filled in the PD Gait and Falls questionnaire198. People with PD presented in their opti-
mally medicated state for all experiments.
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Data acquisition gait experiments. EEG, EMG and kinematic events (heel strike and toe off) were 
recorded while participants performed both gait conditions (overground and treadmill). Bipolar surface EMG 
was recorded from the left and right tibialis anterior muscle (TA) and filtered at 1–1000 Hz. Simultaneously, EEG 
signals were recorded using water-based AgCl electrodes placed at 10 cortical sites according to the international 
10–20 standard (P3, P4, C3, Cz, C4, F7, F3, Fz, F4, F8), and filtered at 1–500 Hz. Footswitches were attached 
onto the participants’ sole at the heel and the big toe of both feet. All signals (EEG, EMG and footswitches) 
were recorded synchronously with a wireless 32-channel amplifier system (TMSi Mobita, The Netherlands) and 
sampled at 2 kHz. The recording system and wireless transmitter were placed in a belt bag and tied around the 
participants’ waist.
Data analysis. All processing of EEG, EMG and footswitch data were performed in MATLAB (2017a) using 
custom written routines.
Prior to spectral analysis, electrophysiological data were normalized to unit variance and pre-processed to 
remove artefacts. EEG channels were first visually inspected and segments with excessive noise (large-amplitude 
movement artefacts, EMG activity) were removed. EEG signals were then band-pass filtered (2nd order 
Butterworth, 0.5–70 Hz) and re-referenced to a common average reference (EEGLAB version 13.6.5)199, as rec-
ommended in Snyder et al.170. Subsequently, independent component analysis (ICA) was performed using the 
extended infomax ICA algorithm implemented in EEGLAB. Independent components containing eye blink, 
muscle, or movement artefacts were removed from the data. On average, 3.8 components (SD 0.9) were removed 
from participants in the healthy young group, 3.9 (SD 0.9) from healthy older participants, and 4.2 (SD 1.0) from 
participants with PD. The remaining components were retained and projected back onto the channels. Finally, 
we calculated bipolar EEG montages based on the monopolar recordings to assess cortical activity from bilateral 
sensorimotor cortices: C3-F3 for the left sensorimotor cortex, and C4-F4 for the right sensorimotor cortex200. 
A differential recording between electrode pairs suppresses far-field contamination and is hence most sensitive 
to local activity generated between the electrode pairs. Thus, it can be used to attenuate artefacts similar to a 
common reference approach (e.g. Snyder et al.170, Petersen et al.79). An example of the processing steps of the 
EEG signals of one healthy older participant during overground walking is shown in the Supplementary Fig. S8. 
Alternative pre-processing and artefact-removal techniques are also presented in the Supplementary Material.
EMG data were high-pass filtered (4th order Butterworth, 20 Hz cut-off) and full-wave rectified using the 
Hilbert transform201. For coherence analysis EMG signals were also demodulated (the Hilbert amplitude was 
normalized while leaving the Hilbert phase unchanged) to avoid spurious coherence estimates resulting from 
periodic changes in EMG amplitude180.
Time-frequency analysis. We then used time-frequency analysis to assess changes in spectral measures 
within the gait cycle. To this end, EEG and EMG signals were segmented into 220 segments of 1-s length (−800 
to +200 ms with respect to heel strike). Heel strike served as reference point (t = 0) in the gait cycle to which 
all segments were aligned. Event-related power and coherence spectra were estimated across the 220 segments 
using Short-time Fourier transform (a 375-ms Hanning window with increments of 25 ms). We computed five 
spectral measures: EEG and EMG power, inter-trial coherence of EEG and EMG signals, and corticomuscular 
coherence202. Event-related EEG power was expressed as percentage change from the average by subtracting and 
dividing by the mean power across the time interval separately for each frequency203. Here we analysed changes in 
relative power and hence focused on phasic changes in power as tonic differences were subtracted away. Relative 
changes in power were computed in single-trial data, i.e. before averaging across gait cycles204. Event-related EMG 
power was log transformed. EMG power was analysed to assess common input to motor neuron pool of the TA 
at these frequencies205. Event-related power and coherence spectra were computed for each participant during 
overground and treadmill walking, and subsequently averaged across participants to render the grand-average 
for each estimate and condition. Additionally, event-related EMG envelopes were computed using filtered and 
rectified EMG data. The EMG envelopes were smoothed (2th order low-pass filter at 45 Hz) and expressed as a 
percentage of the peak amplitude within the gait cycle206.
Statistical analysis. The significance level (alpha) was set at 0.05 for all statistical analyses, which were per-
formed in SPSS (version 25). Linear mixed models (LMM) were used to compare gait parameters across groups. 
Fixed effect factors included in the model were group (young, old and PD) and condition (overground, treadmill). 
The random effect was participant. When a significant main effect was found for a comparison, Fisher’s LSD was 
used as post-hoc test.
Clinical measures available for the old and PD groups (ACE-R, MMSE, visual function measures, tactile sen-
sitivity, ABC, ASCQ) were compared between groups via independent samples t-tests. Disease characteristics 
of PD such as MDS-UPDRS scores, Hoehn & Yahr (H&Y), Gait and Falls questionnaire (GFQ) and levodopa 
equivalent daily dosage (LEDD) were summarised as group means.
Coherence (corticomuscular coherence and inter-trial coherence) was transformed to z-scores for statistical 
comparison between groups and conditions. A parametric approach was used to convert magnitude-squared 
coherence to p-values207, and we then used the standard normal distribution to convert p-values into z-scores80, 
which have an expected value of 0 and a standard deviation of 1 under the null hypothesis (EEG and EMG signals 
are independent).
We used LMMs again to compare spectral measures across groups and conditions. Spectral estimates (EEG 
power, EMG power, EEG inter-trial coherence, EMG inter-trial coherence, corticomuscular coherence) were 
assessed in five time-frequency windows of interest: Double support (0–125 ms relative to heel strike) at theta 
(4–7 Hz), alpha (8–12 Hz), lower beta (13–20 Hz), higher beta (21–30 Hz), and gamma frequencies (31–45 Hz). 
Hence, 25 separate LMMs were completed (one for each outcome measure and frequency band), and the false 
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discovery rate was controlled using the Benjamini-Hochberg procedure96. We used a Matlab script to control the 
false discovery rate97. The fixed effect factors included in the LMMs were group and condition, and the random 
effect was participant (i.e. using the participant identification number), which accounts for the repeated spectral 
measures. Statistically significant main effects were followed up with post-hoc comparisons (Fisher’s LSD). We 
also calculated Cohen’s ds of all possible pairwise group comparisons as a measure of effect size. For this we used 
the ESCI intro software208.
The same LMM was used to compare the EMG envelopes across groups and conditions. To this end, the EMG 
amplitude was averaged over two time windows within the gait cycle in each group: 1. during early swing between 
−0.4 to −0.25 s relative to heel strike (foot lift phase), 2. between 0.04 and 0.08 s (foot drop) relative to heel strike. 
Post-hoc comparisons (Fisher’s LSD) for significant main effects were also completed.
Subsequently, EMG amplitude during both time intervals was correlated with corticomuscular coherence over 
significant time-frequency windows within each of the groups (young, old and PD) and conditions (treadmill and 
overground).
Data availability
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